Metabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study
- PMID: 26857595
- DOI: 10.7326/M15-1323
Metabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study
Abstract
Background: The risk for chronic kidney disease (CKD) among obese persons without obesity-related metabolic abnormalities, called metabolically healthy obesity, is largely unexplored.
Objective: To investigate the risk for incident CKD across categories of body mass index in a large cohort of metabolically healthy men and women.
Design: Prospective cohort study.
Setting: Kangbuk Samsung Health Study, Kangbuk Samsung Hospital, Seoul, South Korea.
Participants: 62 249 metabolically healthy, young and middle-aged men and women without CKD or proteinuria at baseline.
Measurements: Metabolic health was defined as a homeostasis model assessment of insulin resistance less than 2.5 and absence of any component of the metabolic syndrome. Underweight, normal weight, overweight, and obesity were defined as a body mass index less than 18.5 kg/m2, 18.5 to 22.9 kg/m2, 23 to 24.9 kg/m2, and 25 kg/m2 or greater, respectively. The outcome was incident CKD, defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m2.
Results: During 369 088 person-years of follow-up, 906 incident CKD cases were identified. The multivariable-adjusted differences in 5-year cumulative incidence of CKD in underweight, overweight, and obese participants compared with normal-weight participants were -4.0 (95% CI, -7.8 to -0.3), 3.5 (CI, 0.9 to 6.1), and 6.7 (CI, 3.0 to 10.4) cases per 1000 persons, respectively. These associations were consistently seen in all clinically relevant subgroups.
Limitation: Chronic kidney disease was identified by a single measurement at each visit.
Conclusion: Overweight and obesity are associated with an increased incidence of CKD in metabolically healthy young and middle-aged participants. These findings show that metabolically healthy obesity is not a harmless condition and that the obese phenotype, regardless of metabolic abnormalities, can adversely affect renal function.
Primary funding source: None.
Comment in
-
Metabolically Healthy Obesity and Development of Chronic Kidney Disease.Ann Intern Med. 2016 Nov 15;165(10):744-745. doi: 10.7326/L16-0405. Ann Intern Med. 2016. PMID: 27842405 No abstract available.
-
Metabolically Healthy Obesity and Development of Chronic Kidney Disease.Ann Intern Med. 2016 Nov 15;165(10):743-744. doi: 10.7326/L16-0406. Ann Intern Med. 2016. PMID: 27842406 No abstract available.
-
Metabolically Healthy Obesity and Development of Chronic Kidney Disease.Ann Intern Med. 2016 Nov 15;165(10):743. doi: 10.7326/L16-0407. Ann Intern Med. 2016. PMID: 27842407 Free PMC article. No abstract available.
-
Metabolically Healthy Obesity and Development of Chronic Kidney Disease.Ann Intern Med. 2016 Nov 15;165(10):742-743. doi: 10.7326/L16-0408. Ann Intern Med. 2016. PMID: 27842408 Free PMC article. No abstract available.
Similar articles
-
The risk of chronic kidney disease in a metabolically healthy obese population.Kidney Int. 2015 Oct;88(4):843-50. doi: 10.1038/ki.2015.183. Epub 2015 Jun 24. Kidney Int. 2015. PMID: 26108064
-
Metabolically healthy obesity and risk of incident CKD.Clin J Am Soc Nephrol. 2015 Apr 7;10(4):578-83. doi: 10.2215/CJN.08980914. Epub 2015 Jan 29. Clin J Am Soc Nephrol. 2015. PMID: 25635035 Free PMC article.
-
Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.Am J Gastroenterol. 2016 Aug;111(8):1133-40. doi: 10.1038/ajg.2016.178. Epub 2016 May 17. Am J Gastroenterol. 2016. PMID: 27185080
-
Metabolic phenotypes of obese, overweight, and normal weight individuals and risk of chronic kidney disease: a systematic review and meta-analysis.Arch Endocrinol Metab. 2019 Jul 29;63(4):427-437. doi: 10.20945/2359-3997000000149. Arch Endocrinol Metab. 2019. PMID: 31365625 Free PMC article.
-
The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta-analysis.Eur J Clin Invest. 2023 Jan;53(1):e13878. doi: 10.1111/eci.13878. Epub 2022 Sep 25. Eur J Clin Invest. 2023. PMID: 36120818
Cited by
-
The effects of weight loss and improved metabolic health status on the risk of non-alcoholic fatty liver disease-results from a prospective cohort in China.Front Nutr. 2023 Nov 28;10:1239996. doi: 10.3389/fnut.2023.1239996. eCollection 2023. Front Nutr. 2023. PMID: 38094922 Free PMC article.
-
Sex-specific association between carbohydrate antigen 19-9 and incident type 2 diabetes.Sci Rep. 2024 Sep 28;14(1):22506. doi: 10.1038/s41598-024-73404-w. Sci Rep. 2024. PMID: 39341838 Free PMC article.
-
Sex Differences in the Relation between Waist Circumference within the Normal Range and Development of Reflux Esophagitis.J Clin Med. 2019 Jan 9;8(1):67. doi: 10.3390/jcm8010067. J Clin Med. 2019. PMID: 30634537 Free PMC article.
-
Hearing Loss and Risk of Overall, Injury-Related, and Cardiovascular Mortality: The Kangbuk Samsung Health Study.J Clin Med. 2020 May 10;9(5):1415. doi: 10.3390/jcm9051415. J Clin Med. 2020. PMID: 32397655 Free PMC article.
-
Relationship of the Blood Pressure Categories, as Defined by the ACC/AHA 2017 Blood Pressure Guidelines, and the Risk of Development of Cardiovascular Disease in Low-Risk Young Adults: Insights From a Retrospective Cohort of Young Adults.J Am Heart Assoc. 2019 Jun 4;8(11):e011946. doi: 10.1161/JAHA.119.011946. Epub 2019 May 29. J Am Heart Assoc. 2019. PMID: 31140347 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical